Literature DB >> 12134176

Randomized prospective study of outcome of short term antiepileptic treatment in small single enhancing CT lesion in brain.

M Gupta1, P Agarwal, G A Khwaja, D Chowdhury, B Sharma, J Bansal, S Anand.   

Abstract

The study was conducted in 81 patients of epilepsy with small single enhancing CT (SSECT) lesion in brain to determine the clinical profile and duration of antiepileptic drugs (AEDs) treatment. The patients were randomly divided into group A (41 cases) and group B (40 cases). Group A patients were treated for 6 months and group B for 1 year with AEDS without cysticidal drugs. The most common mode of presentation was simple partial motor seizures with secondary generalization in both the groups. Repeat imaging of brain (CT/MRI) at 6 months showed disappearance of lesion in 82.94% in group A and 87% in group B, while persistence of lesion was present only in 4.87% in group A and 5% in group B. 87.81% patients in group A and 87.17% in group B were seizure free. The recurrence of seizure occurred in 12.19% cases in group A, and 12.82% in group B. 80% of these patients had calcified lesion in both the groups. This study reveals that SSECT lesion with epilpesy is a benign self-limiting disease. It also reveals that 6 months AED treatment is as effective as one year treatment. Patients having calcified lesion or persistence of lesion might require long term AED treatment.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12134176

Source DB:  PubMed          Journal:  Neurol India        ISSN: 0028-3886            Impact factor:   2.117


  8 in total

1.  Cranial computed tomography in partial motor seizures.

Authors:  Jageer Hussain; S Srinivasan; V Tiroumourougane Serane; S Mahadevan; S Elangovan; V Bhuvaneswari
Journal:  Indian J Pediatr       Date:  2004-07       Impact factor: 1.967

Review 2.  Antiepileptic drugs for seizure control in people with neurocysticercosis.

Authors:  Marta Frackowiak; Monika Sharma; Tejinder Singh; Amrith Mathew; Benedict D Michael
Journal:  Cochrane Database Syst Rev       Date:  2019-10-14

3.  A diagnostic and therapeutic scheme for a solitary cysticercus granuloma.

Authors:  G Singh; V Rajshekhar; J M K Murthy; S Prabhakar; M Modi; N Khandelwal; H H Garcia
Journal:  Neurology       Date:  2010-12-14       Impact factor: 9.910

Review 4.  Drug therapy for solitary cysticercus granuloma: a systematic review and meta-analysis.

Authors:  Willem M Otte; Monika Singla; Josemir W Sander; Gagandeep Singh
Journal:  Neurology       Date:  2012-12-26       Impact factor: 9.910

5.  Diagnosis and Treatment of Neurocysticercosis: 2017 Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH).

Authors:  A Clinton White; Christina M Coyle; Vedantam Rajshekhar; Gagandeep Singh; W Allen Hauser; Aaron Mohanty; Hector H Garcia; Theodore E Nash
Journal:  Clin Infect Dis       Date:  2018-04-03       Impact factor: 9.079

Review 6.  Antiepileptic drugs for seizure control in people with neurocysticercosis.

Authors:  Dean Walton; Hannah Castell; Ceryce Collie; Greta Karen Wood; Monika Sharma; Tejinder Singh; Benedict D Michael
Journal:  Cochrane Database Syst Rev       Date:  2021-11-01

7.  The effectiveness of anti-inflammatory and anti-seizure medication for individuals with single enhancing lesion neurocysticercosis: A meta-analysis and expert group-based consensus recommendations.

Authors:  Annette Abraham; Javier A Bustos; Hélène Carabin; Robert de Meijere; Priyadarshi S Sahu; Vedantam Rajshekhar; Gagandeep Singh; A Clinton White; Peter L Chiodini; Sarah Gabriël; Mamoun Homeida; Theodore Nash; Bernard Ngowi; Xiao Nong Zhou; Christina Coyle; Hector H Garcia; Andrea S Winkler
Journal:  PLoS Negl Trop Dis       Date:  2021-03-31

8.  Diagnosis and Treatment of Neurocysticercosis: 2017 Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH).

Authors:  A Clinton White; Christina M Coyle; Vedantam Rajshekhar; Gagandeep Singh; W Allen Hauser; Aaron Mohanty; Hector H Garcia; Theodore E Nash
Journal:  Am J Trop Med Hyg       Date:  2018-04       Impact factor: 2.345

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.